Skip to content
10-K

Annual Report

TECTONIC THERAPEUTIC, INC. TECX

0001193125-26-076793

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 16, 2026 18.78M sh
Shares Diluted FY 2025 · Dec 31, 2025 18.32M sh
Shares Diluted FY 2025 · Dec 31, 2024 8.49M sh
Capex FY 2025 · Dec 31, 2025 $208K
Capex FY 2025 · Dec 31, 2024 $156K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$60.08M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$59.08M
Cash And Equivalents FY 2025 · Dec 31, 2025 $253.8M
Cash And Equivalents FY 2025 · Dec 31, 2024 $141.24M
Stockholders Equity FY 2025 · Dec 31, 2025 $251.33M
Stockholders Equity FY 2025 · Dec 31, 2024 $140.78M
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$84.64M
Current Liabilities FY 2025 · Dec 31, 2025 $9.67M
Current Liabilities FY 2025 · Dec 31, 2024 $11.61M
Total Liabilities FY 2025 · Dec 31, 2025 $9.71M
Total Liabilities FY 2025 · Dec 31, 2024 $12.13M
Current Assets FY 2025 · Dec 31, 2025 $257.36M
Current Assets FY 2025 · Dec 31, 2024 $146.86M
Total Assets FY 2025 · Dec 31, 2025 $261.04M
Total Assets FY 2025 · Dec 31, 2024 $152.91M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.05
Eps Diluted FY 2025 · Dec 31, 2024 −$6.83
Eps Basic FY 2025 · Dec 31, 2025 −$4.05
Eps Basic FY 2025 · Dec 31, 2024 −$6.83
Rd Expense FY 2025 · Dec 31, 2025 $63.49M
Rd Expense FY 2025 · Dec 31, 2024 $41.36M
Net Income FY 2025 · Dec 31, 2025 −$74.15M
Net Income FY 2025 · Dec 31, 2024 −$57.98M
Operating Income FY 2025 · Dec 31, 2025 −$84.04M
Operating Income FY 2025 · Dec 31, 2024 −$58.02M